The International Corporate Governance Network, representing institutional investors with more than $18 trillion in assets, supports lobbying disclosure as best practice and supports disclosure of any amounts over $10,000, including trade association payments. Proxy advisor, ISS, also supports this proposal. Publicly available data does not provide a complete picture of UnitedHealth's lobbying expenditures. UnitedHealth's board and its shareholders need complete disclosure to be able to evaluate the use of corporate assets for direct and grassroots lobbying and the risks for spending poses to shareholders. We urge shareholders to vote for this proposal. Thank you. Dannette L. Smith Thank you, Mr. Mills. The shareholder proposal will be approved if holders of a majority of shares of our common stock present vote for the proposal. Under Minnesota law, abstentions have the effect of a vote against the proposals and broker non-votes have no effect. Has everyone who wishes to vote had a chance to do so?